Tata Memorial Centre to provide affordable high-dose MIBG therapy for neuroblastoma
Mumbai: A high-dose MIBG (metaiodobenzylguanidine) therapy for treating neuroblastoma, a type of cancer mostly found in children, will be provided at an affordable cost of Rs 7-8 lakh at a research body associated with the
Tata Memorial Centre
(
TMC
).
The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), a unit of TMC at Kharghar in Navi Mumbai, treated a 17-year-old with a supra-high dose of 131I-mIBG on May 5.
Talking to reporters on Friday, TMC director Dr Sudeep Gupta said the treatment of children with high-risk neuroblastoma, which requires a multi-modality approach including anti-GD2 immunotherapy, costs around Rs 75 lakh and has a long-term cure outcome of 50 per cent.
"The anti-GD2 immunotherapy is exceptionally expensive and is not accessible to many patients in India. However, the high-dose
131I-mIBG therapy
costing Rs 7-8 lakh is affordable. With 41 'hot beds' medical isolation ward, the largest in the world, the TMC plans to routinely provide this treatment to eligible patients with high-risk neuroblastoma," he said.
Even the toilet and wash water from the room are piped to a sealed "delay-decay" tank so the radioactivity can fade before the wastewater is released into the regular sewer system.
Live Events
This is the first high-dose 131I-mIBG therapy administered in India with a 25-35 per cent long-term cure outcome, where the patient was administered 800 mCI of 131I-mIBG.
In India, the standard dose of 131I-mIBG is 5 millicuries per kilogram (maximum 300 mCI).
"The previous highest total dose of 131I-mIBG in a single setting in India has been 300 mCI. Specialists from the departments of nuclear medicine, paediatric oncology, haematological oncology (bone marrow transplant) and transfusion medicine were involved in the planning and execution of this complex treatment," Dr Gupta said.
For the higher dose, the Atomic Energy Regulatory Board (AERB) gave its approval after the TMC submitted a report from a simulation experiment at the premises, addressing issues such as isolation protocols, radiation safety concerns, dosimetry calculations, patient monitoring and management of emergency crises.
He said this treatment requires coordination of doctors, physicists, technical staff, nurses and auxiliary staff from the departments of nuclear medicine, paediatric and haematological oncology (bone marrow transplant unit) and transfusion medicine, and the Board of Radiation and Isotope Technology (BRIT).
In India, 1,500 children are detected with neuroblastoma annually, Dr Gupta added. PTI
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
an hour ago
- Hans India
APMC brings renewal services to district level
Tirupati: In a significant move to decentralise medical registration services, the Andhra Pradesh Medical Council (APMC) launched district-level doctor registration renewals and re-registration services at SV Medical College (SVMC) in Tirupati on Saturday. With this, doctors no longer need to travel to Vijayawada for services other than permanent registration, offering relief to hundreds of medical professionals in the region. The two-day registration drive was inaugurated by district Collector Dr S Venkateswar in the presence of APMC Chairman Dr Daggumati Sreehari Rao. Speaking to the media, Dr Venkateswar described the initiative as a welcome development and urged senior doctors, practicing physicians, and medical students to take full advantage of the services now available locally. He commended the APMC for introducing long-pending reforms that have brought greater ease and flexibility in availing council services. 'The decentralisation of the registration process is a major step forward. I request APMC to continue introducing innovative measures to make the process even more accessible,' he said. Dr Sreehari Rao highlighted that the APMC plans to offer these services at district level every weekend, starting with this initiative in Tirupati. The move aims to reduce travel burdens on senior citizens and practicing doctors seeking re-registration, renewals, or No Objection Certificates (NOCs). A key change introduced includes a reduction in service fees. Doctors under 75 years of age will now pay Rs 8,000 for registration-related services, while those above 75 will pay Rs 6,000, significantly lower than the previous Rs 40,000–Rs 50,000 range. Changes have also been made to Continuing Medical Education (CME) credit requirements. Doctors aged 65–70 now need only 15 credit points over five years, while those between 71–80 need 10. Those above 80 years are exempt. Dr Sreehari Rao announced that meritorious final-year MBBS students from all government and private colleges will be awarded gold medals annually. APMC is also working on WhatsApp-based services for renewals and introducing AI tools to monitor CME attendance. On this occasion, doctors appealed to the Collector for a permanent APMC office in Tirupati to facilitate registrations with more flexibility. The Collector assured that a decision would be taken after discussions with APMC. MLC Dr Cipai Subramanyam also spoke on the occasion, which was attended by SVMC Principal Dr G Ravi Prabhu, SVIMS Director Dr RV Kumar, Superintendents of Ruia and Maternity hospitals Dr J Radha and Dr Prameela, DM&HO Dr V Balakrishna Naik and others.
New Indian Express
an hour ago
- New Indian Express
NIMHANS Northern campus in Bengaluru gets Centre's nod
BENGALURU: The Union Government has granted in-principle approval for the construction of a 300-bed Post-Graduate Polytrauma Centre under the National Institute of Mental Health and Neurosciences (NIMHANS) at Kyalasanahalli near Kempegowda International Airport (KIA), Bengaluru. The facility, estimated to cost Rs 498 crore, is aimed at providing advanced emergency and trauma care to accident victims in and around the Bengaluru region. The approval was issued by the Department of Expenditure under the Union Ministry of Finance, following a proposal submitted by the Ministry of Health and Family Welfare (MoHFW). The land for the project, measuring 39 acres, had been allotted to NIMHANS in 2012-13, during the tenure of the BJP-led state government in Karnataka. The proposed facility will serve as NIMHANS' Northern Campus and will include not just the trauma hospital, but also residential quarters for staff, hostels, guest houses, administrative blocks, and other support infrastructure. The Finance Ministry has laid down several conditions for the project. These include optimising manpower and infrastructure as recommended by NITI Aayog in its 2021 report, ensuring the trauma centre also caters to regular patients, and monitoring outputs and outcomes regularly for mid-course corrections. The ministry has also asked the Health Ministry to frame a long-term national policy for emergency and serious injury care. The Centre will provide critical care for patients suffering from multiple and complex injuries, particularly head, brain, chest, abdomen, and skeletal trauma, during the crucial 'Golden Hour.'
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
HPV key factor for rise in cancer cases among Indian youth, say doctors
A growing number of oncologists across India have expressed concern over Human Papillomavirus (HPV) becoming a major contributing factor in the rise of cancers in young Indians, particularly among those in their twenties and thirties. With increasing cases of cervical, oral, and oropharyngeal cancers linked to HPV infection, experts believe India is on the brink of a preventable cancer crisis if urgent measures are not implemented. Dr Ashish Gupta, Chief of Medical Oncology at Amerix Cancer Hospital, New Delhi, said, "HPV-related cancers are striking far earlier than we used to see. Patients in their twenties are coming in with cervical, oral, and throat cancers -- many of which could have been avoided entirely with timely vaccination and proper awareness." "What's most heartbreaking is that HPV is preventable, yet many families and individuals are not even aware of the risk," Dr Gupta said. Unlike other cancers that develop over decades, HPV-related cancers in young people often progress rapidly and silently. Prevention through vaccination and early screening should be treated with the same urgency as any national health emergency. "We need a focused, stigma-free, countrywide campaign that reaches schools, colleges, and parents," Gupta said. The virus, which spreads primarily through intimate skin-to-skin contact, is known to be one of the most common sexually transmitted infections globally. While the body clears most HPV infections on its own, certain high-risk strains can persist and lead to cancer. In women, it is the leading cause of cervical cancer, while in men and women alike, it is now strongly linked to oral, anal, and throat cancers. What troubles experts further is the lack of awareness and the social stigma that surrounds HPV discussions in India -- leading to poor vaccination rates and negligible screening coverage. Dr Shubham Garg, Senior Oncologist at Dharamshila Narayana Superspeciality Hospital said, "HPV-related cancers don't give you many symptoms early on. That's why routine screening is so vital. A young woman with no symptoms may already have precancerous changes in the cervix. Similarly, oral HPV infections in men often go unnoticed until they present with full-blown tumors. Without education, vaccination, and routine checkups, we're allowing preventable cancers to spread unchecked." Currently, India does not have a national HPV vaccination program for all adolescents, although the vaccines are approved and available in private settings. Global studies have proven that vaccinating both boys and girls before they become sexually active significantly reduces HPV transmission and related cancers. Experts believe that adopting universal HPV immunization for preteens, along with catch-up vaccinations for older teens and young adults, is the most effective strategy to curb this epidemic. However, vaccination alone isn't enough. Dr Ashish Gupta further said that screening must become as commonplace and normalized as any other preventive health check. "Our focus must be twofold -- educate and empower. The stigma surrounding HPV has kept us silent for too long. We must normalize conversations about the virus and its connection to cancer. Pap smears, HPV DNA tests, and oral screenings should be accessible in every district hospital and primary health center, he said. Moreover, we need policies that include these services under national insurance schemes so that cost is never a barrier. We are not talking about an incurable disease. We are talking about a cancer that we can, in many cases, prevent before it even begins. That's a rare opportunity in oncology and one we must not waste," Dr Gupta added. Dr Rahul Bhargava, Senior Oncologist at Fortis Memorial Research Institute, Gurugram concluded with a powerful reminder, "Every vaccinated child is one less cancer case in our future. Every screening that catches early-stage HPV impact is a life redirected toward health and hope. Let's not wait until it's too late. Prevention, in this case, is not just better than cure'?it's the only rational path forward. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
